Biotechnology can make a positive difference in everyone’s lives. From cancer to the common cold, biotech companies have become instrumental in helping understand the ailments that have mystified the medical community for decades. Biotech companies work hard to study diseases and, more importantly, find treatments and cures for them.
The biotechnology sector of the market started getting headlines as companies scrambled to find a solution to the COVID-19 pandemic.
My research shows a growing trend in the sector that can earn investors sizable profits in the years to come. Plus, chief investment strategist Adam O’Dell considers biotech the next big wave in the stock market.
In this episode of The Bull & The Bear, I tell you about the biotech sector and explain the best way to invest in this growing trend moving forward.
Biotech Sector Grows at a Hypersonic Pace
The biotech sector started, like many others, very small. Biopharmaceuticals was dominated by only a few players in the game. Its $149 billion in revenue for 2012 accounted for only 19% of the global pharmaceutical revenue that year, but its growth has been on a rapid upward trajectory ever since.
By 2026, as the sub-sector continues to expand, pharma revenue from biotechnology is expected to grow to $505 billion — more than 35% of all pharmaceutical revenue.
That puts the biotech sector growth at 239% from 2012 to 2026.
This is massive growth for the biotech industry. Listen to The Bull & The Bear to find out how to play it.
Pro tip: Adam hit a home run with his first biotech recommendation to his Green Zone Fortunes subscribers. They locked in gains of 90% on one half of the position, and the other half is up almost 190% now! He released his next big biotech stock in the October issue of Green Zone Fortunes. To find out more about this service … and how to get his next big genomics stock recommendation … click here.
The Bull & The Bear
Led by Adam O’Dell and a team of finance journalists, traders and experts, Money & Markets gives you the information you need to protect your nest egg, grow your wealth and safeguard your financial well-being.
You can listen to The Bull & The Bear on Apple Podcasts, Spotify, Amazon and Google Podcasts. Make sure to subscribe and leave us a review.
Be sure to also subscribe to our YouTube channel for more videos like my weekly Marijuana Market Update. You can find more investing insights from Adam and Green Zone Fortunes co-editor Charles Sizemore in our Ask Adam Anything and revamped Investing With Charles videos, respectively.
Have something you want us to talk about? Email thebullandthebear@moneyandmarkets.com and give us your thoughts.
Check out moneyandmarkets.com, and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary, and actionable advice.
Also, follow us on:
Safe trading,
Matt Clark, CMSA®
Research Analyst, Money & Markets
Matt Clark is the research analyst for Money & Markets. He is a certified Capital Markets & Securities Analyst with the Corporate Finance Institute and a contributor to Seeking Alpha. Prior to joining Money & Markets, he was a journalist and editor for 25 years, covering college sports, business and politics.